ZA949929B - Sugar-coated pharmaceutical dosage unit. - Google Patents
Sugar-coated pharmaceutical dosage unit.Info
- Publication number
- ZA949929B ZA949929B ZA949929A ZA949929A ZA949929B ZA 949929 B ZA949929 B ZA 949929B ZA 949929 A ZA949929 A ZA 949929A ZA 949929 A ZA949929 A ZA 949929A ZA 949929 B ZA949929 B ZA 949929B
- Authority
- ZA
- South Africa
- Prior art keywords
- sugar
- dosage unit
- pharmaceutical dosage
- coated pharmaceutical
- steroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93203645 | 1993-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA949929B true ZA949929B (en) | 1995-08-23 |
Family
ID=8214236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA949929A ZA949929B (en) | 1993-12-23 | 1994-12-13 | Sugar-coated pharmaceutical dosage unit. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5662936A (xx) |
| EP (1) | EP0659432B1 (xx) |
| JP (1) | JPH07206681A (xx) |
| KR (1) | KR100330560B1 (xx) |
| CN (1) | CN1108929A (xx) |
| AT (1) | ATE155039T1 (xx) |
| AU (1) | AU685538B2 (xx) |
| CA (1) | CA2138451C (xx) |
| DE (2) | DE69404116T2 (xx) |
| DK (1) | DK0659432T3 (xx) |
| ES (1) | ES2105501T3 (xx) |
| FI (1) | FI116035B (xx) |
| GR (1) | GR3024817T3 (xx) |
| NO (1) | NO305273B1 (xx) |
| NZ (1) | NZ270228A (xx) |
| ZA (1) | ZA949929B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
| EP0792152B1 (en) * | 1994-11-22 | 2004-04-14 | Balance Pharmaceuticals, Inc. | Methods of contraception |
| US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| PT927556E (pt) * | 1997-09-23 | 2000-12-29 | Akzo Nobel Nv | Unidades de dosagem de esteroides com um revestimento para selagem destes |
| GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| MXPA02003645A (es) * | 1999-10-11 | 2003-07-28 | Ml Lab Plc | Aparato suministrador de medicamento con revestimiento resistente a la humedad. |
| US6254888B1 (en) | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
| AU4278301A (en) * | 2000-03-27 | 2001-10-08 | Kyowa Hakko Kogyo Co. Ltd. | Easy-to-take granule |
| ATE315930T1 (de) * | 2000-05-18 | 2006-02-15 | Therics Inc | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform |
| JP2002068965A (ja) * | 2000-08-31 | 2002-03-08 | Teikoku Hormone Mfg Co Ltd | 単層糖衣錠及びその製造方法 |
| WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
| US7303763B2 (en) * | 2001-02-12 | 2007-12-04 | Watson Laboratories, Inc. | Compositions for conjugated estrogens and associated methods |
| GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
| US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
| CA2562386C (en) | 2004-04-21 | 2014-11-18 | Innovata Biomed Limited | Inhaler |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| DE602005023193D1 (de) * | 2004-10-15 | 2010-10-07 | Suedzucker Ag | Verbessertes trommelcoating-verfahren |
| JP4808453B2 (ja) * | 2005-08-26 | 2011-11-02 | 株式会社荏原製作所 | 研磨方法及び研磨装置 |
| JP2009509974A (ja) * | 2005-09-23 | 2009-03-12 | スレッシュオールド ファーマシューティカルズ， インコーポレイテッド | 抗癌治療 |
| CN103281913A (zh) * | 2010-12-29 | 2013-09-04 | 雀巢产品技术援助有限公司 | 包含团聚的油粉的糖果产品 |
| BR112014033005A2 (pt) * | 2012-07-03 | 2017-06-27 | Nestec Sa | produto de confeitaria compreendendo pó oleoso aglomerado |
| WO2014079592A1 (en) * | 2012-11-22 | 2014-05-30 | Evonik Industries Ag | Process for preparing a granulated product from a powder composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2736682A (en) * | 1954-10-11 | 1956-02-28 | Victor M Hermelin | Method of making a prolonged action medicinal tablet |
| US3576663A (en) * | 1967-05-29 | 1971-04-27 | Colorcon | Coated tablet |
| US3577512A (en) * | 1968-10-11 | 1971-05-04 | Nat Patent Dev Corp | Sustained release tablets |
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
| IE67345B1 (en) * | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
-
1994
- 1994-12-13 ZA ZA949929A patent/ZA949929B/xx unknown
- 1994-12-19 CA CA002138451A patent/CA2138451C/en not_active Expired - Fee Related
- 1994-12-20 JP JP6316645A patent/JPH07206681A/ja active Pending
- 1994-12-20 US US08/360,157 patent/US5662936A/en not_active Expired - Lifetime
- 1994-12-21 NZ NZ270228A patent/NZ270228A/en not_active IP Right Cessation
- 1994-12-22 DK DK94203732.6T patent/DK0659432T3/da active
- 1994-12-22 NO NO944991A patent/NO305273B1/no not_active IP Right Cessation
- 1994-12-22 FI FI946043A patent/FI116035B/fi active IP Right Grant
- 1994-12-22 ES ES94203732T patent/ES2105501T3/es not_active Expired - Lifetime
- 1994-12-22 KR KR1019940035926A patent/KR100330560B1/ko not_active IP Right Cessation
- 1994-12-22 AU AU81684/94A patent/AU685538B2/en not_active Ceased
- 1994-12-22 DE DE69404116T patent/DE69404116T2/de not_active Expired - Fee Related
- 1994-12-22 CN CN94119182A patent/CN1108929A/zh active Pending
- 1994-12-22 EP EP94203732A patent/EP0659432B1/en not_active Expired - Lifetime
- 1994-12-22 DE DE0659432T patent/DE659432T1/de active Pending
- 1994-12-22 AT AT94203732T patent/ATE155039T1/de not_active IP Right Cessation
-
1997
- 1997-09-24 GR GR970402451T patent/GR3024817T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0659432A1 (en) | 1995-06-28 |
| CN1108929A (zh) | 1995-09-27 |
| FI946043A (fi) | 1995-06-24 |
| FI116035B (fi) | 2005-09-15 |
| NO944991D0 (no) | 1994-12-22 |
| NO305273B1 (no) | 1999-05-03 |
| ES2105501T3 (es) | 1997-10-16 |
| NO944991L (no) | 1995-06-26 |
| EP0659432B1 (en) | 1997-07-09 |
| KR950016715A (ko) | 1995-07-20 |
| GR3024817T3 (en) | 1998-01-30 |
| ATE155039T1 (de) | 1997-07-15 |
| DK0659432T3 (da) | 1998-02-16 |
| FI946043A0 (fi) | 1994-12-22 |
| DE659432T1 (de) | 1997-01-30 |
| AU8168494A (en) | 1995-06-29 |
| US5662936A (en) | 1997-09-02 |
| DE69404116T2 (de) | 1997-11-13 |
| CA2138451A1 (en) | 1995-06-24 |
| KR100330560B1 (ko) | 2002-09-05 |
| DE69404116D1 (de) | 1997-08-14 |
| CA2138451C (en) | 2007-04-24 |
| JPH07206681A (ja) | 1995-08-08 |
| NZ270228A (en) | 1995-09-26 |
| AU685538B2 (en) | 1998-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3024817T3 (en) | Sugar-coated pharmaceutical dosage unit. | |
| UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
| OA09772A (en) | "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". | |
| CA2304770A1 (en) | A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds | |
| AU5587690A (en) | Treatment of postmenopausal disorders | |
| HU9603584D0 (en) | Sterol derivatives which applicable for regulation of meiosis | |
| UA41909C2 (uk) | Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат | |
| CA2166332A1 (en) | Antiglucocorticoid steroids for the treatment of anxiety disorders | |
| IL103516A0 (en) | Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| EP0221728A3 (en) | Monosaccharide containing wound healing preparation | |
| GB9414966D0 (en) | Pharmaceutical compositions for the nasal administration of antiviral agents | |
| ZA941464B (en) | Use of pregnane derivative | |
| GR3025872T3 (en) | Orally active derivatives of 1,3,5(10)-estratriene | |
| IL109866A (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it | |
| TW218011B (xx) | ||
| IL110780A0 (en) | Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold | |
| ES2065855A1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
| ES8801267A1 (es) | Procedimiento para preparar derivados de isoquinolinona | |
| HU9402237D0 (en) | Use of benzene-sulfonyl-indol derivatives for producing pharmaceutical compositions | |
| AU1067795A (en) | Use of lithium compounds in the treatment and prevention of alzheimer's disease | |
| AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
| IL122731A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia |